Full Story, Every View.
Published loading...Updated

Sotagliflozin Offers Benefits in Type 2 Diabetes With Reduced Kidney Function

Summary by MedPage Today
(MedPage Today) -- ORLANDO -- Even type 2 diabetes patients with impaired renal function saw improvements in weight and glycemic control with a dual SGLT1/2 inhibitor, according to a meta-analysis. Among nearly 4,000 adults, those with a baseline...

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

EverydayHealth.com broke the news in on Friday, May 16, 2025.
Sources are mostly out of (0)

Similar News Topics